Original Query: ALL
Previous Study | Return to List | Next Study

Open Label Study of Long Term Safety Evaluation of Alirocumab (ODYSSEY OLE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01954394
Recruitment Status : Completed
First Posted : October 1, 2013
Last Update Posted : December 8, 2017
Regeneron Pharmaceuticals
Information provided by (Responsible Party):

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : June 30, 2017
  Study Completion Date : June 30, 2017